Purpose: To investigate the usefulness of screening for patient symptoms as the fifth vital sign using an electronic medical recording system. Patients and methods: In the electronic medical recording system, all admitted patients received routine nurse-based assessment of discomfort (defined as any physical symptom) at every vital sign check regarding item 2 of the Support Team Assessment Schedule Japanese version (STAS-J). All cancer patients admitted to oncology units were screened at 1-week intervals. Screening-positive was defined when patients had a STAS-J score of 2 or more at least two times in a week. For all screening-positive patients, the palliative care team reviewed each patient's medical records, and provided written recommendations as needed. The primary outcomes were the proportion of screening-positive patient, and the proportion of patients deemed to need additional palliative treatment in the screening-positive patients. Results: Of 2427 patients screened, 223 (9.1%; 95% confidence interval, 8-10%) met the screeningpositive criterion. A total of 12 (5.4%; 95% confidence interval, 3-9%) of them were deemed to need additional palliative care, including six patients referred to the PCT within 1 week. In the remaining 211 screening-positive patients, 100 had received adequate palliative care, 68 had already been referred to the palliative care team and 43 had self-limiting transient discomfort. Conclusion: This screening system was feasible but the majority of screening-positive patients did not require additional palliative care interventions.
Introduction
Symptoms of patients with advanced cancer are often overlooked and undertreated (1) (2) (3) . To identify patients with undetected symptoms, a variety of screening programs have been recently implemented (4) (5) (6) , and several empirical studies suggested the clinical efficacy of the screening programs (7) (8) (9) (10) (11) (12) (13) (14) (15) .
The fifth vital sign can be a potential alternative procedure. The concept of the 'fifth vital sign' was first developed by the American Pain Society, stating that the evaluation of pain should be a routine requirement of care (16) (17) (18) (19) (20) (21) .
We previously demonstrated the feasibility and potential usefulness of screening for patient symptoms with fifth vital sign using electronic medical records, with the aim of identifying patients with undertreated physical symptoms (21) . The study indicated that the screening program was well-implemented during the pilot phase (i.e. 9 weeks), and contributed to identifying undertreated patients among all admitted patients with cancer (11% of all screened patients). In that study, however, the number of patients screened was relatively small and the study period was short. In our hospital, a screening program using the fifth vital sign has since been implemented as a part of routine medical practice. Clarifying the proportion of screening-positive patient and patients who deemed to need additional palliative treatment in daily clinical practice using longer period and larger samples may be of value.
The aim of this brief report was to investigate the real-world usefulness of a screening program using the fifth vital sign in electronic medical records. The primary endpoints were the proportion of screening-positive patient, and the proportion of patients deemed to need additional palliative treatment in the screening-positive patients.
Patients and methods
We conducted a retrospective analysis of prospectively-gathered data with the screening program using the fifth vital sign in electronic medical records for cancer patients at the Seirei Mikatahara Hospital, a designated cancer hospital in Japan. This study was approved by the Institutional Review Board of our hospital.
Screening program
In this screening program, ward nurses recorded the intensity of symptoms of all patients at each vital sign check (routinely at least three times per day) using item 2 of the Support Team Assessment Schedule Japanese version (STAS-J) to identify patients with marked physical symptoms (22) (23) (24) (25) . The levels of patient symptoms were described in the electronic medical records along with the vital sign data. A symptom was conceptualized as any physical symptom, such as pain, dyspnea, nausea, fatigue or constipation. The rationale to target multiple symptoms in addition to pain was their high prevalence and marked impact on patients' quality of life (26) (27) (28) . Psychological distress was not included despite its well-acknowledged importance in patients' quality of life, because: (1) routine assessment of multiple items would be a significant burden to nurses, and (2) medical professionals cannot always provide exact proxy assessment of patients' psychological distress (29, 30) .
We defined screening-positive as patients with the STAS score of 2 or more. This cut-off points identified patients with severe symptom (NRS > = 7) with sensitivity of 0.68 and specificity of 0.82.
We applied the computer-based program to screen the scores of the STAS-J in electronic medical records. The program extracted the patients had a STAS-J score of 2 or more at least two times in a week, and made a list of the patients with STAS-J score of 2 or more automatically. We performed this computer-based screening program once a week, all cancer patients admitted to oncology units. Patients who had undergone surgery in the previous 2 weeks were excluded.
For all patients identified as being positive by screening, the palliative care team reviewed each patient's medical records, and evaluated: (1) whether the patient actually suffered physical symptoms, and (2) whether the patient received adequate palliative treatment. The interdisciplinary team discussed whether the patient needed further intervention by the palliative care team. If the palliative care team determined that additional treatments might improve the patient's physical symptoms, written recommendations were added to the medical records. This process required~3 min for each patient. The palliative care team comprises of one attending physician (palliative care specialist, clinical experience: 22 years), one certified nurse (clinical experience: 20 years), one pharmacist, and receives regular support from liaison psychiatry, a pain service, rehabilitation, oral care and social work division.
Subjects and procedures
Study subjects were all patients admitted to oncology units in the Seirei Mikatahara Hospital from May 2014 to April 2015. At weekly intervals, after the palliative care team review medical records, the primary investigator (AN) recorded the following items for each patient: age, sex, primary cancer site, symptoms identified (e.g. pain, dyspnea, nausea, fatigue and constipation), whether the patient had already been referred to the palliative care team, whether the palliative care team judged that the patient received adequate palliative treatment, whether additional palliative treatment was needed, and the contents of the additional treatment the patient actually received (i.e. provided written recommendation by the palliative care team, referred to palliative care team within a week, and referred to another specialized support team).
Statistical analyses
The primary endpoints were the proportion of screening-positive patients and the proportion of patients deemed to need additional palliative treatment in the screening-positive patients.
Using the recorded data, the following items were calculated: the total number of all screened patients, the total number of screeningpositive patients, the number of patients deemed to need additional palliative care treatment in the screening-positive patients and the number of patients not requiring additional palliative treatment in the screeningpositive patients. The proportion of screening-positive patients was defined as the total number of screening-positive patients/the total number of all screened patients. The proportion of the patients deemed to need additional palliative treatment in the screening-positive patients was defined as the number of patients deemed to need additional palliative care treatment/the total number of screening-positive patients. The details of symptoms were classified into two groups: symptoms due to cancer itself and other self-limited transient symptoms.
Results
In the 12-month observation period, a total of 2 427 patients were screened, and 223 cases (9.1%, 95% confidence intervals, [8] [9] [10] met the positive screening criteria (Fig. 1) . The backgrounds of the patients screened as positive are summarized in Table 1 . The lung was the most frequent of primary cancer site.
Of the 223 patients screened as positive, a total of 12 patients (5.4% of screening-positive patients, 95% confidence intervals, [3] [4] [5] [6] [7] [8] [9] were deemed to need additional palliative care. Of them, six were referred to the palliative care team within 1 week, four were referred to other specialized support teams (i.e. chemotherapy support team or oral care team), and two cases were recommended potentially useful interventions for symptom control by the palliative care team.
Of the remaining 211 patients, 100 were determined by the palliative care team to receive adequate palliative treatment, 68 already had been referred to the palliative care team, and 43 had selflimiting transient symptoms. Transient symptoms were related to: (1) invasive procedures (e.g. chest tube, nephrostomy, and intubation, n = 17), (2) chemotherapy and/or radiation (n = 5), and (3) benign complications (e.g. bowel obstruction, acute exacerbation on chronic obstructive lung disease and pneumonia, n = 21).
Discussion
This study confirmed the findings of our previous study that a relatively small number of patients needed additional palliative treatment among those identified by screening using the fifth vital sign. We found that the majority of screening-positive patients had already received appropriate palliative treatment.
The most important findings were that the proportion of screening-positive patients as well as the proportion of patients deemed to need additional palliative treatment among the screeningpositive patients were approximately the same as in our previous study. Compared with the figures of existing studies using other screening programs, the frequency of patients with potentially undertreated symptoms was low in this study (12, 17, 31) . The potential interpretations of this discrepancy are: (1) our screening program could not adequately detect patients with severe symptoms, and (2) recording the fifth vital sign itself could function as an education tool, that is, nurses paid attention to the patients with marked symptoms and adopted proactive measures using the fifth vital signs as a part of their routine practice. In addition, our hospital's specialized palliative care system had been fully established, and thus patients with severe symptoms tend to be referred to the palliative care team earlier.
There is a possibility that nurses underestimated patient's symptoms. To date, many studies suggest that physicians and nurses generally tend to underestimate patient's symptoms (32, 33) . The reliability using the STAS, however, was confirmed in previous studies (23, 25) . We believe, therefore, underestimation of patient's symptom intensity is unlikely in this study population.
Another important finding was the high-level feasibility of program implementation. This study confirmed that this computerbased program could be used for complete screening within a few minutes, and the review of medical records by the palliative care team required~3 min per patient. The program caused no patient burden and had only a minimal burden on nurses differently from paper-and-pencil format (15) .
This study had several limitations. Firstly, STAS-J item 2 is a clinician-proxy assessment and not patient-reported outcome. This screening program was performed within routine clinical practice, and there were no efforts to compare symptom severity between proxyrated and patient-reported measures on designing the study protocol. Secondly, because the targets of this screening program were physical symptoms, psychological distress and social issues were not evaluated.
This study has several research implications to further explore useful screening programs using the fifth vital sign. One is to compare the proportion of screening-positive patients in a variety of institutions where different levels of specialized palliative care are provided, e.g. having no palliative care team, low palliative care team activity or having no screening system.
In conclusion, the screening program using the fifth vital sign was feasible, but its usefulness should be further studied in institutions with a variety of palliative care provisions. 
